Dr. Pospisil’s primary focus is to assist biotechnology  and biopharmaceutical companies in recruiting for  positions such as chief executive officer, chief business  officer, chief financial officer, chief commercial officer,  chief medical officer, head of research and  development and other key executives. Mr. Pospisil  also assists with C-level searches for science and  technology leadership in innovative enterprises in  energy, chemistry, materials and technology. He has  co-led numerous technology and science – related  nonprofit CEO searches.

With over fifteen years prior experience in the industry  as a successful executive and investor, Mr. Pospisil  brings a thoughtful perspective to executive search,  shaped by a breadth of experiences in new product development, business development, M&A, financings, strategy, company building, operational leadership and  board functions from start-up, growth to mature  biotechnology and biopharmaceutical companies.

Prior to joining Korn Ferry, Dr. Pospisil was a co-founder and managing partner of both Aduro Capital LLC, an investment management company focused on  the public healthcare sector and Aduro Partners LLC, an advisory firm focused on helping venture-backed  and public life science companies assess, evaluate, partner opportunities and build businesses.

Previously, he was a partner in life science investments  at Atlas Venture and earlier was with Millennium Pharmaceuticals, where his last position was director,  strategy leadership. Earlier, he was a new product  manager at Altus Biologics, a spin-out of Vertex  Pharmaceuticals.

Dr. Pospisil holds a doctor of philosophy in organic chemistry from Harvard University and a bachelor’s degree in biochemistry from New York University. He also attended Harvard Business School’s Program for Management Development (PMD). Dr. Pospisil is an American Chemical Society Member since 1989 and an active Board Member of Société de Chimie Industrielle and The Mark Foundation for Cancer Research.